Four ways to work together
From a single due diligence engagement to a 12-month interim mandate. Each engagement is scoped and priced to fit the specific situation.
Buy-side and sell-side | Fixed scope | Investor-ready output
Technology due diligence
An independent technical assessment of a regulated technology business, delivered in a format that stands up to investor and board scrutiny. This is not a code review. It is a structured evaluation of technical risk, AI maturity, regulatory compliance posture, and team capability — the questions that determine whether an acquisition, investment, or fundraise carries hidden technical liability.
I work on both sides of the transaction. Buy-side for PE and VC firms evaluating a target. Sell-side for founders preparing for Series B, Series C, or exit — where a credible technical assessment ahead of the process removes friction and prevents late-stage surprises.
What the assessment covers
- Stack and architecture review. Scaling risks and decision points ahead.
- AI approach and maturity. What is actually in production versus what is on the roadmap, and whether the approach is appropriate for the use case.
- Regulatory compliance posture. FDA, MHRA, ISO 27001, ISO 42001, GCP, HIPAA, EU AI Act readiness — assessed against the actual regulatory obligations of the business, not a generic checklist.
- Team and delivery evaluation. Is the engineering organisation structured correctly for this stage? Where are the capability and capacity gaps?
- Investment risk summary. A clear, honest, jargon-free assessment in a format suitable for board packs, investment committee presentations, and data rooms.
Who it is for
PE firms and operating partners evaluating regulated HealthTech or clinical trials technology. VC investors who need independent technical verification before a round closes. Founders preparing for a funding process who want to identify and address technical risk before investors do.
What you will have at the end
A document you can put in front of your investment committee, your board, or your acquirer. The kind of assessment that gives senior stakeholders confidence rather than questions.
Pricing: on request. Scoped per engagement.
Get in touch about due diligence →
3 to 12 months | Regulated sector | Transformation and exit-ready
Interim CTO
Senior technology leadership for regulated businesses that need an experienced CTO without the timeline, cost, or risk of a permanent hire. I work directly with the CEO and board, lead the engineering organisation, and carry accountability for technology strategy, AI delivery, and regulatory compliance — for as long as the mandate requires.
This is not fractional in the diluted sense. When I take an interim mandate, it is the primary engagement. The business gets a CTO with full accountability, not a consultant who dips in once a week.
What the mandate typically covers
- Engineering leadership and team development. Architecture decisions, hiring guidance, and team structure for the stage you are at.
- AI strategy and delivery. What to build, in what sequence, with what governance in place. Built around your regulatory obligations and business model, not the latest benchmark.
- Regulatory compliance. Wherever the gap is — ISO 42001, ISO 27001, FDA, MHRA, GCP, CQC — I have closed it before in environments where getting it wrong had real consequences.
- Board and investor presence. I attend board meetings and investor sessions as your technology leadership voice. Your stakeholders get a credible senior technical presence immediately, not in six months when a permanent hire has settled in.
- IR35 status. Determined at engagement stage. Outside and inside IR35 rates are available.
Who it is for
PE-backed HealthTech and RegTech scale-ups navigating transformation or preparing for exit. Series B and C companies where the technology organisation needs to be materially stronger before the next raise. Boards that need senior technology leadership in place quickly, without sacrificing quality.
What you will have at 90 days
A technology organisation that operates with more clarity, an AI programme that is moving toward production rather than pilot, and a board pack that reflects a function under control.
Pricing: on request.
Get in touch about an interim engagement →
6 to 8 weeks | Fixed deliverables | ISO 42001 and EU AI Act
AI governance sprint
A time-boxed engagement for regulated organisations that have AI in use or in development and need the governance framework to match. In six to eight weeks, we go from "we have AI running in parts of the business" to "we have a governance framework we can defend to a regulator, an auditor, or a board."
ISO 42001 was published in December 2023. Most implementation guidance in the market is theoretical. I have implemented it at two regulated healthcare organisations. The sprint is built around that direct experience, not around reading the standard.
What the sprint covers
- AI use audit. Every AI system in use across the organisation, approved and unapproved. You will know what is actually running before the sprint ends, because shadow AI is always the first finding.
- ISO 42001 gap analysis. Where the current state sits against the standard, with a clear and prioritised path to certification readiness.
- EU AI Act compliance posture. Which systems fall under which risk tier, what obligations apply, and what needs to change before August 2026 enforcement.
- Governance framework design. Policies, review processes, human oversight structures, and documentation in implementable form — not a PowerPoint.
- 90-day implementation roadmap. What to do after the sprint ends, in what order, with what resources.
Who it is for
HealthTech, clinical trials, and MedTech companies preparing for ISO 42001 certification. Boards and leadership teams facing regulatory scrutiny of AI systems. PE portfolio companies where an upcoming audit includes AI governance as a scope item.
What you will have at the end
A governance framework you can implement, a clear certification readiness position, and a regulator-ready evidence trail for the AI systems currently in production.
Pricing: fixed fee. On request.
Get in touch about an AI governance sprint →
Rolling monthly | Light touch | By referral or application
Board and strategic advisory
An independent senior technology voice for boards and founders who have engineering leadership in place but want external perspective at the level where technology decisions intersect with investment strategy, regulatory risk, and commercial outcomes.
I work with a small number of organisations at this level at any one time. The value is in genuine independence: no vendor relationships, no equity position, no incentive other than giving you an honest view.
What this looks like in practice
- Quarterly technology strategy review. A half-day session reviewing where the technology organisation is against where it needs to be, with written output suitable for board circulation.
- Investor call preparation. Framing technical progress in commercial language, anticipating hard questions before they are asked in the room.
- Technical risk assessment for board packs. An independent read of the technology section before it goes to the board or an investor.
- On-call availability for major decisions. Architecture changes, AI stack choices, significant vendor contracts. One to two hours a month for the decisions that benefit from a senior external view.
Who it is for
Series B and later founders who have a CTO or senior engineer but want an independent perspective at board level. PE operating partners who want ongoing technical oversight of portfolio companies. Boards where regulated technology and AI governance decisions need a credible non-executive voice.
Pricing: monthly retainer. On request. By referral or application.
Apply for board advisory →
